130 related articles for article (PubMed ID: 19993175)
1. A case of myasthenia gravis showing recurrent monocular paralytic manifestations.
Behrman S
Proc R Soc Med; 1945 Oct; 38(12):664-5. PubMed ID: 19993175
[No Abstract] [Full Text] [Related]
2. Myasthenia mimicking monocular elevation deficiency.
Kee C; Cha DM; Ahn J; Hwang JM
J Child Neurol; 2013 Jan; 28(1):108-10. PubMed ID: 22408146
[TBL] [Abstract][Full Text] [Related]
3. Adhesive ileus complicating recurrent intestinal pseudo-obstruction in a patient with myasthenia gravis.
Seretis C; Seretis F; Gemenetzis G; Gourgiotis S; Lagoudianakis E; Pappas A; Keramidaris D; Salemis N
Case Rep Gastroenterol; 2012 May; 6(2):425-8. PubMed ID: 23055952
[TBL] [Abstract][Full Text] [Related]
4. [Paralytic crises in myasthenia gravis].
AGREST A; ALVAREZ A; RONCORONI AJ
Medicina (B Aires); 1961; 21():41-75. PubMed ID: 13859656
[No Abstract] [Full Text] [Related]
5. [Pseudo-paralytic myasthenia gravis: Erb-Goldflam disease].
ROGER H
Sem Hop; 1953 Jan; 29(7):313-21. PubMed ID: 13076248
[No Abstract] [Full Text] [Related]
6. Myasthenia gravis associated with invasive malignant thymoma: two case reports and a review of the literature.
Beydoun SR; Gong H; Ashikian N; Rison RA
J Med Case Rep; 2014 Oct; 8():340. PubMed ID: 25312448
[TBL] [Abstract][Full Text] [Related]
7. Unsuccessful attempt to demonstrate a paralytic factor in serum of myasthenia gravis patients.
VAN DER MOST VAN SPIJK D
Acta Physiol Pharmacol Neerl; 1956 Mar; 4(4):591-4. PubMed ID: 13313178
[No Abstract] [Full Text] [Related]
8. Unsuccessful attempt to demonstrate a paralytic factor in serum of myasthenia gravis patients.
LAMMERS W; MOST VAN SPIJK D
Nature; 1954 Jun; 173(4416):1192-3. PubMed ID: 13176414
[No Abstract] [Full Text] [Related]
9. [Ocular myasthenia gravis].
Sanadze AG; Sidnev DV; Tumurov DA; Afanasieva OI
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(9):116-120. PubMed ID: 37796078
[TBL] [Abstract][Full Text] [Related]
10. Isolated laryngeal myasthenia gravis for 26 years.
Renard D; Hedayat A; Gagnard C
Neuromuscul Disord; 2015 Feb; 25(2):153-4. PubMed ID: 25454167
[TBL] [Abstract][Full Text] [Related]
11. New-onset Myasthenia Gravis after SARS-CoV-2 infection: case report and literature review.
Tereshko Y; Gigli GL; Pez S; De Pellegrin A; Valente M
J Neurol; 2023 Feb; 270(2):601-609. PubMed ID: 36352330
[TBL] [Abstract][Full Text] [Related]
12. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
13. Recurrent anterior hip dislocation in a patient with myasthenia gravis: a case report.
Özkazanlı G; Karaman Ö; Beng K; Muratlı HH
Acta Orthop Traumatol Turc; 2015; 49(1):106-10. PubMed ID: 25803263
[TBL] [Abstract][Full Text] [Related]
14. Pembrolizumab-induced Myasthenia Gravis: Literature Review of Ocular Manifestations and a Refractory Case.
Dugena O; Zheng C; Taylor J; Wong A
J Immunother; 2022 Jul-Aug 01; 45(6):267-273. PubMed ID: 35575994
[TBL] [Abstract][Full Text] [Related]
15. Myasthenia gravis associated with Graves' disease in Japan.
Ohno M; Hamada N; Yamakawa J; Noh J; Morii H; Ito K
Jpn J Med; 1987 Feb; 26(1):2-6. PubMed ID: 3573405
[TBL] [Abstract][Full Text] [Related]
16. [ORL manifestations of myasthenia gravis].
Bravo Domínguez O; Foglia Fernández M; González Compte X; Jiménez Montoya R; Girons Bonells J; Dicenta Sousa M
Acta Otorrinolaringol Esp; 2000; 51(6):549-51. PubMed ID: 11142795
[TBL] [Abstract][Full Text] [Related]
17. Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review.
Jones SC; Sorbello A; Boucher RM
Drug Saf; 2011 Oct; 34(10):839-47. PubMed ID: 21879778
[TBL] [Abstract][Full Text] [Related]
18. Autologous hematopoietic stem cell transplant for the treatment of refractory myasthenia gravis with anti-muscle specific kinase antibodies.
Beland B; Hahn C; Jamani K; Chhibber S; White C; Atkins H; Storek J
Muscle Nerve; 2023 Feb; 67(2):154-157. PubMed ID: 36527328
[TBL] [Abstract][Full Text] [Related]
19. A case of isolated plexiform neurofibroma in a patient with myasthenia gravis.
Back SJ; Kim DH; Kim N; Lee Y; Seo YJ; Park JK; Lee JH
Ann Dermatol; 2009 Feb; 21(1):53-5. PubMed ID: 20548857
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and treatment status of antiacetylcholine receptor antibody-positive ocular myasthenia gravis.
Isshiki Y; Mimura O; Gomi F
Jpn J Ophthalmol; 2020 Nov; 64(6):628-634. PubMed ID: 32936398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
